Ranbaxy Laboratories Ltd today reported a consolidated loss of Rs 761 crore for the first quarter ended March 31, 2009.
The company had reported a profit of Rs 85.8 crore in the same quarter last year.
Sales dipped by 4 per cent to Rs 1,558.4 crore in the first quarter of the current year compared to Rs 1,623.1 crore in the same period last year, the company said in statement.
In the first quarter, the company's sales in North America declined by 7 per cent to Rs 404 crore compared to Rs 435.1 crore in the same quarter last year.
Ranbaxy also reported a 14 per cent decline in its sales in Europe at 283.1 crore for the March quarter compared to Rs 329 crore in the same quarter last year.
